These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 1834013

  • 21. In vivo activities of evernimicin (SCH 27899) against vancomycin-susceptible and vancomycin-resistant enterococci in experimental endocarditis.
    Souli M, Thauvin-Eliopoulos C, Eliopoulos GM.
    Antimicrob Agents Chemother; 2000 Oct; 44(10):2733-9. PubMed ID: 10991853
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Treatment of experimental endocarditis due to multidrug-resistant Enterococcus faecium with clinafloxacin and penicillin.
    Zaman MM, Landman D, Burney S, Quale JM.
    J Antimicrob Chemother; 1996 Jan; 37(1):127-32. PubMed ID: 8647753
    [Abstract] [Full Text] [Related]

  • 24. Efficacy of teicoplanin-gentamicin given once a day on the basis of pharmacokinetics in humans for treatment of enterococcal experimental endocarditis.
    López P, Gavaldà J, Martin MT, Almirante B, Gomis X, Azuaje C, Borrell N, Pou L, Falcó V, Pigrau C, Pahissa A.
    Antimicrob Agents Chemother; 2001 May; 45(5):1387-93. PubMed ID: 11302800
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Efficacy of tigecycline alone and in combination with gentamicin in the treatment of experimental endocarditis due to linezolid-resistant Enterococcus faecium.
    Pontikis K, Pefanis A, Tsaganos T, Tzepi IM, Carrer DP, Giamarellou H.
    Antimicrob Agents Chemother; 2013 Jul; 57(7):3392-4. PubMed ID: 23587961
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Antibiotic resistance among enterococci causing endocarditis in the UK: analysis of isolates referred to a reference laboratory.
    Johnson AP, Warner M, Woodford N, Speller DC, Livermore DM.
    BMJ; 1998 Sep 05; 317(7159):629-30. PubMed ID: 9727989
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Antibiotic treatment of experimental endocarditis due to vancomycin- and ampicillin-resistant Enterococcus faecium.
    Whitman MS, Pitsakis PG, Zausner A, Livornese LL, Osborne AJ, Johnson CC, Levison ME.
    Antimicrob Agents Chemother; 1993 Oct 05; 37(10):2069-73. PubMed ID: 8257125
    [Abstract] [Full Text] [Related]

  • 31. First documented isolation of vancomycin-resistant Enterococcus faecium in Sweden.
    Melhus A, Tjernberg I.
    Scand J Infect Dis; 1996 Oct 05; 28(2):191-3. PubMed ID: 8792490
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Contribution of animal models in the search for effective therapy for endocarditis due to enterococci with high-level resistance to gentamicin.
    Eliopoulos GM, Thauvin-Eliopoulos C, Moellering RC.
    Clin Infect Dis; 1992 Jul 05; 15(1):58-62. PubMed ID: 1319757
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Expression of glycopeptide-resistance gene in response to vancomycin and teicoplanin in the cardiac vegetations of rabbits infected with VanB-type Enterococcus faecalis.
    Lefort A, Arthur M, Depardieu F, Chau F, Pouzet C, Courvalin P, Fantin B.
    J Infect Dis; 2004 Jan 01; 189(1):90-7. PubMed ID: 14702158
    [Abstract] [Full Text] [Related]

  • 36. Daptomycin compared with teicoplanin and vancomycin for therapy of experimental Staphylococcus aureus endocarditis.
    Kaatz GW, Seo SM, Reddy VN, Bailey EM, Rybak MJ.
    Antimicrob Agents Chemother; 1990 Nov 01; 34(11):2081-5. PubMed ID: 1963526
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Aminoglycoside resistant enterococcal endocarditis.
    Eliopoulos GM.
    Infect Dis Clin North Am; 1993 Mar 01; 7(1):117-33. PubMed ID: 8463648
    [Abstract] [Full Text] [Related]

  • 39. European Glycopeptide Susceptibility Survey of gram-positive bacteria for 1995. European Glycopeptide Resistance Survey Study Group.
    Felmingham D, Brown DF, Soussy CJ.
    Diagn Microbiol Infect Dis; 1998 Aug 01; 31(4):563-71. PubMed ID: 9764397
    [Abstract] [Full Text] [Related]

  • 40. [Glycopeptide resistant enterococci. Occurrence, distribution, resistance transmission, significance].
    Klare I, Witte W.
    Wien Klin Wochenschr; 1997 May 09; 109(9):293-300. PubMed ID: 9265387
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.